104 COVID-19 test kits now available for commercial use in PH | Inquirer News

104 COVID-19 test kits now available for commercial use in PH

/ 01:03 PM May 27, 2020

MANILA, Philippines — There are now 104 COVID-19 test kits available for commercial use in the Philippines after the Food and Drug Administration (FDA) recently approved 11 more testing kits—four polymerase chain reaction (PCR)-based kits and seven antibody rapid test kits.

The newly-approved kits are from China, Korea, the United States, Ireland, and Turkey.

Of the total number of approved test kits, only one came from the Philippines—the GenAmplify™ Corona Virus 2019 (COVID-19) rRT PCR Detection kit which was manufactured by Manila HealthTek, Inc.

Article continues after this advertisement

It was developed in collaboration with the Philippine Genome Center (PGC) and the University of the Philippines – National Institutes of Health (UP-NIH) with support from the DOST – Philippine Council for Health Research and Development (DOST-PCHRD).

FEATURED STORIES

However, the Department of Health announced last week that the UP-NIH had recalled the first locally-made coronavirus test kits over “very minor” defects.

Below is the complete list of FDA-approved COVID-19 test kits as of May 22:

/MUF
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, FDA, Health, NcoV, Outbreak, Philippines, test kits

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.